Indoco Remedies on Thursday
said it has received approval from the US health regulator to market a generic diabetes medication
The company's product is the generic equivalent of Invokamet tablets.
Indoco said it plans to produce the medication at its manufacturing facility in Goa.
Canagliflozin and Metformin Hydrochloride Tablets are used to treat type 2 diabetes mellitus.
"This milestone underscores our commitment to bringing affordable and effective treatment options to patients managing type 2 diabetes," Indoco Remedies
MD Aditi Panandikar said.
|